These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1367898)

  • 1. Bioconversion of the sodium salt of simvastatin (MK-733) to 6-desmethyl-6-alpha-hydroxymethyl simvastatin.
    Marcin C; White R; Hirsch C; Ferris F; Sykes R; Houck D; Greasham R; Chartrain M
    J Ind Microbiol; 1991 Oct; 8(3):157-64. PubMed ID: 1367898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a large-scale continuous substrate feed process for the biotransformation of simvastatin by Nocardia s.p.
    Gbewonyo K; Buckland BC; Lilly MD
    Biotechnol Bioeng; 1991 May; 37(11):1101-7. PubMed ID: 18597342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolic inversion of the 6'chiral center of simvastatin.
    Vickers S; Duncan CA
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1508-15. PubMed ID: 1764101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
    Nagata Y; Hidaka Y; Ishida F; Kamei T
    Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioconversion of avermectin into 27-OH avermectin.
    Chartrain M; White R; Goegelman R; Gbewonyo K; Greasham R
    J Ind Microbiol; 1990 Dec; 6(4):279-84. PubMed ID: 1366995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive effect of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis in cholesterol-fed rabbits].
    Oogushi K
    Fukuoka Igaku Zasshi; 1991 Feb; 82(2):36-47. PubMed ID: 2022360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient bioconversion of compactin to pravastatin by the quinoline-degrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil.
    Lin CL; Tang YL; Lin SM
    Bioresour Technol; 2011 Nov; 102(22):10187-93. PubMed ID: 21974888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-669,262, a potent HMG-CoA reductase inhibitor.
    Joshua H; Schwartz MS; Wilson KE
    J Antibiot (Tokyo); 1991 Mar; 44(3):366-70. PubMed ID: 2026562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-examining the role of the gut microbiota in the conversion of the lipid-lowering statin monacolin K (lovastatin) into its active β-hydroxy acid metabolite.
    Beltrán D; Frutos-Lisón MD; Espín JC; García-Villalba R
    Food Funct; 2019 Apr; 10(4):1787-1791. PubMed ID: 30882807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biosynthesis of simvastatin--a mini-review].
    Yang Z; Gan C
    Sheng Wu Gong Cheng Xue Bao; 2008 Mar; 24(3):349-54. PubMed ID: 18589807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor response to simvastatin in familial defective apo-B-100.
    Corsini A; Mazzotti M; Fumagalli R; Catapano AL; Romano L; Romano C
    Lancet; 1991 Feb; 337(8736):305. PubMed ID: 1671145
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
    Nordin C; Dahl ML; Eriksson M; Sjöberg S
    Lancet; 1997 Jul; 350(9070):29-30. PubMed ID: 9217719
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of simvastatin (MK-733) on branched pathway of mevalonate.
    Nagata Y; Hidaka Y; Ishida F; Kamei T
    Jpn J Pharmacol; 1990 Nov; 54(3):315-24. PubMed ID: 2090840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid lowering drugs.
    Bocanegra TS; Tobert JA
    BMJ; 1990 May; 300(6733):1195. PubMed ID: 2112035
    [No Abstract]   [Full Text] [Related]  

  • 15. Generation of statin drug metabolites through electrochemical and enzymatic oxidations.
    Khera S; Hu N
    Anal Bioanal Chem; 2013 Jul; 405(18):6009-18. PubMed ID: 23760135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivatives.
    Duggan ME; Alberts AW; Bostedor R; Chao YS; Germershausen JI; Gilfillan JL; Halczenko W; Hartman GD; Hunt V; Imagire JS
    J Med Chem; 1991 Aug; 34(8):2489-95. PubMed ID: 1875346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors.
    Vyas KP; Kari PH; Pitzenberger SM
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1155-62. PubMed ID: 2306236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnological production and applications of statins.
    Barrios-González J; Miranda RU
    Appl Microbiol Biotechnol; 2010 Jan; 85(4):869-83. PubMed ID: 19820926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex difference in metabolism of simvastatin by rat hepatic microsomes.
    Ohtawa M; Uchiyama N
    Eur J Drug Metab Pharmacokinet; 1992; 17(3):175-81. PubMed ID: 1490485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and practical applications of simvastatin.
    Mauro VF
    Clin Pharmacokinet; 1993 Mar; 24(3):195-202. PubMed ID: 8343198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.